Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Sinusitis
ADR ID BADD_A04008
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.07      Respiratory tract infections
22.07.03      Upper respiratory tract infections NEC
22.07.03.007      Sinusitis
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.13      Upper respiratory tract infections
11.01.13.005      Sinusitis
Description A disorder characterized by an infectious process involving the mucous membranes of the paranasal sinuses. [CTCAE] Inflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES. [MeSH]
MedDRA Code 10040753
MeSH ID D012852; D012852; D012852; D012852; D015523; D012852; D015521
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Sinus infection | Sinusitis | Sinusitis NOS | Pansinusitis | Rhinosinusitis | Maxillary sinusitis | Paranasal sinus infection | Sinusitis recurrent | Ethmoiditis | Ethmoidal sinusitis | Sinusitides | Sinus Infections | Infection, Sinus | Infections, Sinus | Sinus Infection
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02308Trovafloxacin mesylate--
BADD_D02315Umeclidinium bromide--
BADD_D02316Unoprostone--
BADD_D02317Unoprostone isopropyl--
BADD_D02319Urofollitropin--
BADD_D02321Ursodiol--
BADD_D02324Valacyclovir hydrochloride--
BADD_D02325Valdecoxib--
BADD_D02326Valganciclovir--
BADD_D02329Valproic acid--
BADD_D02331Valsartan--
BADD_D02334Vandetanib--
BADD_D02335Vardenafil--
BADD_D02336Vardenafil hydrochloride--
BADD_D02337Varenicline--
BADD_D02342Vedolizumab--
BADD_D02345Venetoclax--
BADD_D02346Venlafaxine--
BADD_D02348Verapamil--
BADD_D02355Vigabatrin--
BADD_D02365Vismodegib--
BADD_D02367Voltaren--
BADD_D02369Voriconazole--
BADD_D02373Warfarin--
BADD_D02377Zafirlukast--
BADD_D02378Zalcitabine--
BADD_D02380Zanamivir--
BADD_D02381Ziconotide--
BADD_D02382Ziconotide acetate--
BADD_D02383Zidovudine--
The 19th Page    First    Pre   19 20    Next   Last    Total 20 Pages